Almost 6 000 health care specialists from all regions of Ukraine have registered to participate in the Teleconference “Respiratory diseases shall be treated in respiratory organs. Respiratory cytoprotection – is it the future perspective or existing opportunity?”, which took place on March 16, 2021.
As part of the event the experts in Pediatrics, Allergology and Pulmonology have shared their thoughts and experience related to respiratory cytoprotection in case of infectious-inflammatory and allergic diseases of airways.
Seven main reports were offered to the participants for review and they were dealing with the following issues:
What is respiratory cytoprotection?
How will it help to improve efficiency of treatment of respiratory diseases?
Who and when should use respiratory cytoprotection?
An opportunity to use nebulizers for treatment of respiratory diseases during pandemic.
Panel discussion by medical experts was devoted to discussion of capabilities of respiratory cytoprotection at different pathological conditions: allergic and infectious rhinitis, bronchitis.
For whom: pediatricians, family doctors, general physician, allergists, pulmonologists.
Association of phthisiatricians and pulmonologists of Ukraine
Infectious Disease Intensive Treatment Association INCURE
Media partner – Asthma and Allergy Magazine.
Didn’t see all the reports? View the video recording of the conference: